Literature DB >> 12638924

Relevance of outlier cases in case mix systems and evaluation of trimming methods.

Francesc Cots1, David Elvira, Xavier Castells, Marc Sáez.   

Abstract

OBJECTIVES: To determine the most appropriate outlier trimming method when the main source of information for case mix classification is length of stay (LOS) because cost information is unavailable.
METHODS: Discharges (35,262) from two public hospitals were analysed. LOS and cost outliers were calculated using different trimming methods. The agreement between cost and LOS trimming was analysed.
RESULTS: The trimming method using the geometric mean with two standard deviations (GM2) showed the highest level of agreement between cost and LOS and revealed the greatest proportion of extreme costs. Nearly 5% of cases were outliers, containing 16% of total LOS. This was the best approximation to 18% of extreme cost because when GM2 was applied to LOS, 88% of outlier cost was revealed.
CONCLUSIONS: The methods were analysed because they are the most frequently used but the same methodology could be employed to compare other outlier determination methods. Outliers should be calculated because they ought to be valued differently from inlier cases.

Entities:  

Mesh:

Year:  2003        PMID: 12638924     DOI: 10.1023/a:1021908220013

Source DB:  PubMed          Journal:  Health Care Manag Sci        ISSN: 1386-9620


  18 in total

Review 1.  The distribution of health care costs and their statistical analysis for economic evaluation.

Authors:  A Briggs; A Gray
Journal:  J Health Serv Res Policy       Date:  1998-10

2.  Case mix measurement in English hospitals: an evaluation of five methods for predicting resource use.

Authors:  N Söderlund; A Gray; R Milne; J Raftery
Journal:  J Health Serv Res Policy       Date:  1996-01

3.  Estimating treatment cost functions for progressive diseases: a multiproduct approach with an application to breast cancer.

Authors:  J R Butler; C M Furnival; R F Hart
Journal:  J Health Econ       Date:  1995-08       Impact factor: 3.883

4.  Judging hospitals by severity-adjusted mortality rates: the influence of the severity-adjustment method.

Authors:  L I Iezzoni; A S Ash; M Shwartz; J Daley; J S Hughes; Y D Mackiernan
Journal:  Am J Public Health       Date:  1996-10       Impact factor: 9.308

5.  Managing the stages of hospital cost accounting.

Authors:  D W Young; L K Pearlman
Journal:  Healthc Financ Manage       Date:  1993-04

Review 6.  Product definition for healthcare contracting: an overview of approaches to measuring hospital output with reference to the UK internal market.

Authors:  N Söderlund
Journal:  J Epidemiol Community Health       Date:  1994-06       Impact factor: 3.710

7.  [Relation of direct hospitalization costs with length of stay].

Authors:  F Cots Reguant; X Castells Oliveres; A García Altés; M Sáez Zafra
Journal:  Gac Sanit       Date:  1997 Nov-Dec       Impact factor: 2.139

8.  Measuring severity of illness: six severity systems and their ability to explain cost variations.

Authors:  J W Thomas; M L Ashcraft
Journal:  Inquiry       Date:  1991       Impact factor: 1.730

9.  Disease staging and PMCs. Can they improve DRGs?

Authors:  K A Calore; L Iezzoni
Journal:  Med Care       Date:  1987-08       Impact factor: 2.983

10.  Use of diagnosis-related groups by non-Medicare payers.

Authors:  G M Carter; P D Jacobson; G F Kominski; M J Perry
Journal:  Health Care Financ Rev       Date:  1994
View more
  11 in total

1.  Cost accounting to determine prices: how well do prices reflect costs in the German DRG-system?

Authors:  Jonas Schreyögg; Oliver Tiemann; Reinhard Busse
Journal:  Health Care Manag Sci       Date:  2006-08

2.  Methods to determine reimbursement rates for diagnosis related groups (DRG): a comparison of nine European countries.

Authors:  Jonas Schreyögg; Tom Stargardt; Oliver Tiemann; Reinhard Busse
Journal:  Health Care Manag Sci       Date:  2006-08

3.  Accounting and reimbursement schemes for inpatient care in France.

Authors:  Martine M Bellanger; Laurent Tardif
Journal:  Health Care Manag Sci       Date:  2006-08

4.  Does the pharmacy expenditure of patients always correspond with their morbidity burden? Exploring new approaches in the interpretation of pharmacy expenditure.

Authors:  Amaia Calderón-Larrañaga; Beatriz Poblador-Plou; Anselmo López-Cabañas; José Tomás Alcalá-Nalvaiz; José María Abad-Díez; Daniel Bordonaba-Bosque; Alexandra Prados-Torres
Journal:  BMC Public Health       Date:  2010-05-11       Impact factor: 3.295

5.  Hospitalist care and length of stay in patients requiring complex discharge planning and close clinical monitoring.

Authors:  William N Southern; Matthew A Berger; Eran Y Bellin; Susan M Hailpern; Julia H Arnsten
Journal:  Arch Intern Med       Date:  2007-09-24

6.  [Identification of pharmacy cost outliers in primary care].

Authors:  Alexandra Prados Torres; Antoni Sicras Mainar; José Estelrich Bennasar; Amaia Calderón Larrañaga; María José Rabanaque Hernández; Anselmo López Cabañas
Journal:  Aten Primaria       Date:  2009-06-10       Impact factor: 1.137

7.  Hierarchical Genetic Algorithm and Fuzzy Radial Basis Function Networks for Factors Influencing Hospital Length of Stay Outliers.

Authors:  Ahmed Belderrar; Abdeldjebar Hazzab
Journal:  Healthc Inform Res       Date:  2017-07-31

8.  Dealing with highly skewed hospital length of stay distributions: The use of Gamma mixture models to study delivery hospitalizations.

Authors:  Eva Williford; Valerie Haley; Louise-Anne McNutt; Victoria Lazariu
Journal:  PLoS One       Date:  2020-04-20       Impact factor: 3.240

9.  Factors influencing hospital high length of stay outliers.

Authors:  Alberto Freitas; Tiago Silva-Costa; Fernando Lopes; Isabel Garcia-Lema; Armando Teixeira-Pinto; Pavel Brazdil; Altamiro Costa-Pereira
Journal:  BMC Health Serv Res       Date:  2012-08-20       Impact factor: 2.655

10.  Impact of alternative approaches to assess outlying and influential observations on health care costs.

Authors:  Thomas Weichle; Denise M Hynes; Ramon Durazo-Arvizu; Elizabeth Tarlov; Qiuying Zhang
Journal:  Springerplus       Date:  2013-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.